Detection in the United Kingdom of the Neisseria gonorrhoeae FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, October to December 2018
Antimicrobial resistance in Neisseria gonorrhoeae is a major public health concern, in particular resistance to ceftriaxone which is the last available drug for empirical monotherapy for gonorrhoea. Here, we report further international spread of the N. gonorrhoeae FC428 clone associated with ceftriaxone resistance and intermediate resistance to azithromycin.
Article: EuroSurveillance
Effective Surveillance